Healthcare

The purpose of this study is to analyze the Mexican healthcare system, comprising the following segments: pharmaceuticals and biotechnology, medical devices, healthcare IT, medical imaging, and clinical diagnostics. Revenue figures and the compound annual growth rate (CAGR) from 2011 to 2015 will be will be examined and compared to the rest of Lati...

This service provides state-of-the-industry insights for companion diagnostic co-development partnerships between drug companies and their diagnostic partners. Topics include drivers for companion diagnostic programs, a comparison of co-development business models, a guide for what drug companies look for in companion diagnostic partners, and an ou...

The market insight provides market definitions, market segmentation, market trends, market size and growth rates, and key market opportunities for the next decade. Segments of the in vitro diagnostics market include immunochemistry testing, microbiology testing, point-of-care testing, molecular testing, hemostasis testing, self-monitoring of blood ...

This issue of Vital Signs, released on September 28, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

The key objective of this research service  is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments.  It also aims...

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...

This issue of Vital Signs, released on September 26, 2012, provides an insight in to the research antibodies market place. The survey captures the purchasing, budget, application, and technology trends of research antibody use. Additionally, the survey determines customer ratings of suppliers, supplier usage, unmet needs, and challenges.

The following market insight provides a review of four companies' approaches to adding value to the molecular diagnostics market. These vendors employed one of four strategies: lowing the cost of molecular diagnostics manufacturing, improving upon the molecular diagnostics sample preparation process, combining established molecular diagnostic techn...

The following market insight provides an overview of the current state of the advanced visualization market in the U.S., evaluating the current adoption of enterprise solutions replacing conventional stand-alone solutions. It also provides an analysis of the competitive dynamics shaping up the advanced visualization industry in the U.S., in light o...